Xpresspa Group Inc (XSPA)
$1.84
0.07 (3.66%)
XSPA Stock Quote Delayed 30 Minutes
Previous Close
$1.91
Market Cap
49.01M
PE Ratio
-1.35
EPS
-1.36
Volume (Avg. Vol.)
1.76M
Day's Range
1.83 - 1.89
52-Week Range
0.05 - 5.74
Dividend & Yield
N/A (N/A)
XSPA Stock Predictions, Articles, and Xpresspa Group Inc News
With Early Deadline Misses, Things Are Looking Desperate for XpresSpa Stock
XpresSpa had a clever idea to cope with the economys' collapse, but investors in XSPA stock are waiting for action to justify their bets.
The Key Question Surrounding XpresSpa Group Right Now
XSPA stock soared as the company pivoted to in-airport coronavirus testing. But even if the pivot works, it's unclear what comes next.
Now at a Nice Price, XpresSpa Stock Is Much More Intriguing
If you had doubts about XSPA stock when it was more expensive, that's understandable. Today, though, the shares trade at a discount price.
The Proposition for XpressSpa Stock Looks Worse and Worse by the Day
XpresSpa has refused to release any information about the financial performance of its testing business. That's a very bad sign for XSPA stock.
Identity Crisis Is Hurting XSPA Stock
XPresSpa is having an identity crisis that is impacting its stock price. Investors should avoid this penny stock until the company figures out a sustainable long-term business plan and decides if it will run airport spas or disease testing and vaccination centers going forward. Until then, buying shares of XSPA is too risky and speculative.
XpresSpa Still Presents More Questions Than Answers
XSPA stock is having a terrific year. Bullish investors believe it can turn into a viable resource for Covid-19 testing. That's a questionable assumption.
XpresSpa Group Earnings: XSPA Stock Grows 6% on Q2 Results
XpresSpa Group (XSPA) earnings for the health and wellness company's second quarter of 2020 have XSPA stock soaring higher after-hours Wednesday.
It’s Now Time to Flip Bullish on XpresSpa
It popped and then dropped, but that won't necessarily be the endgame for contentious yet promising XSPA stock.
Why XpresSpa Is Much More than the Bears Think
XSPA stock isn't a pump-and-dump penny stock scheme; this is an innovative company executing strongly against a huge long-term opportunity.
Is ExpresSpa Group a Buy? The Math Says Yes!
With so many variables impacting XSPA stock, it’s difficult to know where the airport health and wellness center will end up. To get some clarity, investors should look at the math.
XpresSpa Shares Are Facing More Problems
With a vaccine potentially two or three months away, XpressSpa appears to be moving at a snail's pace, increasing the risk posed by XSPA stock.
XpresSpa Isn’t Worth Investor Money Regardless of Its Core Business
Right now, XSPA stock doesn't make sense under any scenario. Speculative investments continue, but nothing is redeeming XpresSpa long-term.
XpresSpa Stock Needs to Overcome Short-Term Troubles
XpresSpa has a loaded balance sheet and tough business. That's why XSPA stock has been so volatile lately. Is that volatility worth buying?
XpresSpa Stock Will Go to Zero Unless Its Covid-19 Plan Works
How did XpresSpa, on the verge of bankruptcy, raise $48 million from investors with its surprising coronavirus plan? And should prospective XSPA stock holders stay away?
XpresSpa Is in a Tough Place With Covid-19 Still in Play
With air travel and consumer spending still nowhere near pre-coronavirus levels, XSPA stock is a risky idea, to put it mildly.
XpresSpa Can’t Relax Regardless of the Pandemic’s Outcome
XSPA stock can't be considered anything more than a speculative stock because the firm's future plans are flimsy at best.
Here Are the Reasons XpresSpa Stock Could Be Worth the Gamble
Say what you will about XpresSpa (NASDAQ:XSPA) pivoting from one business model to another but the future of XSPA stock depends on it.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
C
